ÂÜÀòÂÒÂ×

Ms. Jessica Burback serves as Accelerator’s Chief of Staff. She supports internal business operations across the firm’s portfolio and oversees strategic communications, investor relations, and priority initiatives for Accelerator’s CEO, Thong Q. Le. Ms. Burback’s efforts play a critical role in the genesis and evolution of each Accelerator portfolio company’s science, technology, and business development activities.

Ms. Burback also serves as head of operations and human resources for several Accelerator portfolio companies, including ApoGen Biotechnologies, Lodo Therapeutics, Proniras Corporation, Rodeo Therapeutics (acquired by Amgen Inc.), and Magnolia Neurosciences. She also serves as the Director of Investor Relations of ALSP Orchid Acquisition Corporation I (NASDAQ: ALORU | ALOR).

Ms. Burback joined Accelerator in 2003, bringing more than 20 years of experience as an operations and human resource professional at biotechnology and pharmaceutical companies.

Before joining Accelerator, Jessica worked at Prolinx, Inc., a private, venture-backed biotechnology company that developed, manufactured, and marketed chemistry-based tools, applications, and systems to advance drug discovery. At Prolinx, Ms. Burback was responsible for many aspects of operations and marketing.

Jessica received an MBA from Seattle University and BA in History from the University of Washington.